Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging

RegulatoryapprovedVueJect®Positive

AI Analysis

Summary

Bracco Imaging announced FDA 510(k) clearance and Health Canada authorization for VueJect®, the first dedicated ultrasound contrast delivery system designed to support cardiology imaging. The clearance strengthens Bracco's ultrasound contrast imaging ecosystem with more standardized and efficient contrast administration.

Outcome Details

U.S. FDA 510(k) clearance and Health Canada authorization

Importance:7/10

Sentiment:

0.80

FDA clearance510(k)medical deviceultrasoundcontrast imagingcardiologyHealth Canada authorization

Related Companies

$INBP $GBCYD $HIT $TRAX

Read the original article

Published by PR Newswire Pharma on August 11, 2026 12:00 PM

Read Original